information database (Lowe and Krulic, 2005). Hearst paid $19 million in settlement and divested Medi-Span (FTC, 2001).

Dr. Kahn proposed that a cross-disciplinary DDI working group be formed to create improved tools for communicating interactions and consequences. He believed that this group could identify and prioritize DDIs, develop a public database capable of receiving all new labeling information on drug interactions, perform an ongoing review of data from the FDA and the published literature, and possibly recommend specific interaction studies. He indicated that a model for the formation of such a group could be found in the National Coordinating Council for Medication Error Reporting and Prevention, an independent partnership of health-care organizations with the goal of reducing medical errors.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement